| Dr Katherine W Khalifeh, MD | |
|
2710 Prosperity Ave, Suite 200, Fairfax, VA 22031-4357 | |
| (703) 280-2841 | |
| Not Available |
| Full Name | Dr Katherine W Khalifeh |
|---|---|
| Gender | Female |
| Speciality | Colorectal Surgery (proctology) |
| Experience | 18 Years |
| Location | 2710 Prosperity Ave, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043356843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 0101252601 (Virginia) | Secondary |
| 208800000X | Urology | 000000 (Maryland) | Secondary |
| 208C00000X | Colon & Rectal Surgery | 0101252601 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Loudoun Hospital | Leesburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairfax Colon And Rectal Surgery Pc | 4385628411 | 19 |
| Inova Health Care Services | 2466351093 | 1725 |
| Fairfax Colon And Rectal Surgery Pc | 4385628411 | 19 |
News Archive
Almost two out of three cancer patients and their families believe that "something good has come out of their experience," according to a recent telephone survey jointly conducted by USA Today, the Kaiser Family Foundation and the Harvard School of Public Health (Szabo, USA Today, 11/21).
Estrogen hormones regulate gene expression. They achieve this by first binding to estrogen receptor in the cell nucleus, which triggers the recruitment of different molecules called coactivators in specific order.
Green chemistry is being employed to develop revolutionary drug delivery methods that are more effective and less toxic - and could benefit millions of patients.
A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics found that AI powered CAD software can reduce hedging and defensive reporting statements in radiologist reports, resulting in clearer more actionable diagnosis descriptions.
Promosome LLC, a biotechnology company uniquely dedicated to the development of technologies related to the regulation of protein synthesis through translation initiation, today announced the signing of a technology license and partnership agreement with Recopharma AB of Stockholm, Sweden. Recopharma is a recognized leader in the research and development of therapeutic recombinant mucin-type fusion proteins.
› Verified 4 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
Almost two out of three cancer patients and their families believe that "something good has come out of their experience," according to a recent telephone survey jointly conducted by USA Today, the Kaiser Family Foundation and the Harvard School of Public Health (Szabo, USA Today, 11/21).
Estrogen hormones regulate gene expression. They achieve this by first binding to estrogen receptor in the cell nucleus, which triggers the recruitment of different molecules called coactivators in specific order.
Green chemistry is being employed to develop revolutionary drug delivery methods that are more effective and less toxic - and could benefit millions of patients.
A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics found that AI powered CAD software can reduce hedging and defensive reporting statements in radiologist reports, resulting in clearer more actionable diagnosis descriptions.
Promosome LLC, a biotechnology company uniquely dedicated to the development of technologies related to the regulation of protein synthesis through translation initiation, today announced the signing of a technology license and partnership agreement with Recopharma AB of Stockholm, Sweden. Recopharma is a recognized leader in the research and development of therapeutic recombinant mucin-type fusion proteins.
› Verified 4 days ago
| Entity Name | Fairfax Colon & Rectal Surgery Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427169507 PECOS PAC ID: 4385628411 Enrollment ID: O20040616000764 |
News Archive
Almost two out of three cancer patients and their families believe that "something good has come out of their experience," according to a recent telephone survey jointly conducted by USA Today, the Kaiser Family Foundation and the Harvard School of Public Health (Szabo, USA Today, 11/21).
Estrogen hormones regulate gene expression. They achieve this by first binding to estrogen receptor in the cell nucleus, which triggers the recruitment of different molecules called coactivators in specific order.
Green chemistry is being employed to develop revolutionary drug delivery methods that are more effective and less toxic - and could benefit millions of patients.
A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics found that AI powered CAD software can reduce hedging and defensive reporting statements in radiologist reports, resulting in clearer more actionable diagnosis descriptions.
Promosome LLC, a biotechnology company uniquely dedicated to the development of technologies related to the regulation of protein synthesis through translation initiation, today announced the signing of a technology license and partnership agreement with Recopharma AB of Stockholm, Sweden. Recopharma is a recognized leader in the research and development of therapeutic recombinant mucin-type fusion proteins.
› Verified 4 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1275097123 PECOS PAC ID: 2466351093 Enrollment ID: O20190509001539 |
News Archive
Almost two out of three cancer patients and their families believe that "something good has come out of their experience," according to a recent telephone survey jointly conducted by USA Today, the Kaiser Family Foundation and the Harvard School of Public Health (Szabo, USA Today, 11/21).
Estrogen hormones regulate gene expression. They achieve this by first binding to estrogen receptor in the cell nucleus, which triggers the recruitment of different molecules called coactivators in specific order.
Green chemistry is being employed to develop revolutionary drug delivery methods that are more effective and less toxic - and could benefit millions of patients.
A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics found that AI powered CAD software can reduce hedging and defensive reporting statements in radiologist reports, resulting in clearer more actionable diagnosis descriptions.
Promosome LLC, a biotechnology company uniquely dedicated to the development of technologies related to the regulation of protein synthesis through translation initiation, today announced the signing of a technology license and partnership agreement with Recopharma AB of Stockholm, Sweden. Recopharma is a recognized leader in the research and development of therapeutic recombinant mucin-type fusion proteins.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katherine W Khalifeh, MD 2710 Prosperity Ave, Suite 200, Fairfax, VA 22031-4357 Ph: (703) 280-2841 | Dr Katherine W Khalifeh, MD 2710 Prosperity Ave, Suite 200, Fairfax, VA 22031-4357 Ph: (703) 280-2841 |
News Archive
Almost two out of three cancer patients and their families believe that "something good has come out of their experience," according to a recent telephone survey jointly conducted by USA Today, the Kaiser Family Foundation and the Harvard School of Public Health (Szabo, USA Today, 11/21).
Estrogen hormones regulate gene expression. They achieve this by first binding to estrogen receptor in the cell nucleus, which triggers the recruitment of different molecules called coactivators in specific order.
Green chemistry is being employed to develop revolutionary drug delivery methods that are more effective and less toxic - and could benefit millions of patients.
A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics found that AI powered CAD software can reduce hedging and defensive reporting statements in radiologist reports, resulting in clearer more actionable diagnosis descriptions.
Promosome LLC, a biotechnology company uniquely dedicated to the development of technologies related to the regulation of protein synthesis through translation initiation, today announced the signing of a technology license and partnership agreement with Recopharma AB of Stockholm, Sweden. Recopharma is a recognized leader in the research and development of therapeutic recombinant mucin-type fusion proteins.
› Verified 4 days ago